LMT
42
5
EMR
37
-3
COF
53
-2
CFG
56
-2
MKC
48
-5
TAP
54
-4
LOW
43
-3
SJM
14
-3
TRV
46
4
PYPL
31
9
ALLE
46
-2
AXP
57
-2
VRTX
48
-5
DG
29
2
UNP
35
-4
EL
15
-2
NI
60
-7
L
52
-3
XEL
55
-5
AMP
63
9
LMT
42
5
EMR
37
-3
COF
53
-2
CFG
56
-2
MKC
48
-5
TAP
54
-4
LOW
43
-3
SJM
14
-3
TRV
46
4
PYPL
31
9
ALLE
46
-2
AXP
57
-2
VRTX
48
-5
DG
29
2
UNP
35
-4
EL
15
-2
NI
60
-7
L
52
-3
XEL
55
-5
AMP
63
9
Financhill
Back

CyberArk Software 10K Form

Sell
32

CYBR
CyberArk Software

Last Price:
$325.18
Seasonality Move:
9.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CYBR News And Ratings

See the #1 stock for the next 7 days that we like better than CYBR

CYBR Financial Statistics

Sales & Book Value

Annual Sales: $1B
Cash Flow: $60.8M
Price / Cash Flow: 69.86
Annual Sales: $47.95
Price / Book: 6.91

Profitability

EPS (TTM): -1.94000
Net Income (TTM): $-93.5M
Gross Margin: $792.4M
Return on Equity: -7.65%
Return on Assets: -3.89%

CyberArk Software Earnings Forecast

Key CyberArk Software Financial Ratios

  • The Gross Profit Margin over the past 14 years for CYBR is 79.18%.
  • The Selling, General & Administrative Expenses for CYBR have been equal to 62.16% of Gross Profit Margin.
  • The Research & Development expenses have been 24.29% of Revenue.
  • The Net Earning history of CYBR is -9.34% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 7 years.

CyberArk Software Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Software
Sector: Information Technology
Current Symbol: CYBR
CUSIP: M2682V
Website: cyberark.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.48
Quick Ratio: 1.42

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 69.32

CYBR Technical Analysis vs Fundamental Analysis

Sell
32
CyberArk Software (CYBR) is a Sell

Is CyberArk Software a Buy or a Sell?

  • CyberArk Software stock is rated a Sell
    The current CyberArk Software [CYBR] share price is $331.30. The Score for CYBR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.